Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Utility of Optical Genome Mapping in the Characterisation of the Global Genomic Architecture of Paediatric Central Nervous System Tumours: A Pilot Study.

Neuropathology and applied neurobiology·2026

Same author

Pancreatic Cancer-Derived Small Extracellular Vesicles Remodel Hepatic Pre-Metastatic Niche via Hybrid Epithelial-Mesenchymal States.

International journal of molecular sciences·2026

Same author

Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stress.

Nucleic acids research·2026

Same author

Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

The New England journal of medicine·2026

Same author

Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia.

American journal of hematology·2026

Same author

Carfilzomib plus induction chemotherapy in children with relapsed or refractory acute lymphoblastic leukemia.

Blood advances·2026

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

Stimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours.

Biagio De Angelis¹, Nicoletta Depalo², Francesca Petronella³

¹Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Journal of Materials Chemistry. B

|February 19, 2020

Summary

Nanoparticles offer new cancer therapies by overcoming drug distribution limits in solid tumors. Combining photothermal therapy (PTT) with immunotherapy shows promise for improved patient outcomes.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Area of Science:

Oncology
Nanomedicine
Biotechnology

Background:

Solid tumors present challenges in cancer treatment due to limited drug distribution.
Established cancer therapies have not significantly reduced mortality rates for solid tumors.
Nanotechnology offers novel strategies to overcome physical barriers in solid tumors.

Purpose of the Study:

To review synergistic approaches combining photothermal therapy (PTT) and immunotherapy for solid tumors.
To explore the role of surface-engineered nanoparticles (NPs) in advanced cancer treatment.
To highlight the potential of drug-free treatments like PTT in oncology.

Main Methods:

Review of literature on nanoparticle-based cancer therapies.
Analysis of NP selection, design, and functionalization for PTT.
Evaluation of thermo-optical properties of NPs for therapeutic applications.
Examination of in vivo studies and clinical trial data.

Main Results:

Surface-engineered nanoparticles, particularly gold nanoparticles (Au NPs), enable drug-free PTT.
PTT leverages stimuli-responsive properties for targeted cancer treatment.
Combination of PTT with immunotherapy presents a significant advancement against solid tumors.

Conclusions:

Nanoparticle-based PTT, especially when combined with immunotherapy, offers a promising therapeutic strategy for solid tumors.
Further research and clinical translation of these synergistic approaches are warranted.
Overcoming drug distribution limitations through nanotechnology is crucial for improving cancer survival rates.